ImmunotherapyIssue Introductions

Immunotherapy: Innovating the Way We Treat Cancer

Dive into this special issue focused on immunotherapy, the innovative methods of treating cancer today, with this introduction by Lillie Shockney, RN, BS, MAS, HON-ONN-CG.
August 2020 – Immunotherapy
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Co-Founder, Academy of Oncology Nurse & Patient Navigators® (AONN+)
Editor-in-Chief, Journal of Oncology Navigation & Survivorship®
University Distinguished Service Professor of Breast Cancer
Professor of Surgery, Johns Hopkins University School of Medicine
Co-Developer, Work Stride: Managing Cancer at Work
Johns Hopkins Healthcare Solutions
Breast cancer survivor

Hello, everyone!

This special issue of CONQUER magazine is about a very innovative way of treating cancer. For many decades, we have been using surgery, chemotherapy, and radiation therapy as the main treatments for different types of cancer.

As a result of laboratory research conducted over the past 3 decades, along with the many patients with cancer who have come before you who have participated in clinical trials, today we have newer therapies that are very innovative and work entirely different from the methods of therapies that use harmful chemicals and have serious side effects, of cutting through the cancer or burning it.

Immunotherapy is different from previous therapies. In this issue, you will find out what immunotherapy is, why it is important, and how it works different from other cancer therapies. You will also learn some other terms that may be new to you, such as the different types of immunotherapy, including checkpoint inhibitors, CAR T-cell therapy, monoclonal antibodies, cytokines, immunomodulators, and cancer vaccines. (If you are on the game show Jeopardy and they have a topic about immunotherapy, you will know all the answers!)

This issue also provides information about how immunotherapy is used in combination with other immunotherapies or with other drugs, such as targeted therapies or chemotherapy drugs improve survival for many patients. You will also learn about new immunotherapies that are now available for the first time for some types of cancer, such as non-melanoma skin cancer.

These new types of immunotherapies bring hope for many patients with cancer who have tried other treatments that are no longer working for them. In fact, CONQUER: the patient voice would not be the “patient voice” if we did not include at least one patient story from a woman who shares her experience of how one of the newer types of immunotherapy—CAR T-cell therapy—has gave her new hope for life after so many other cancer treatments failed her.

This is an exciting time in the cancer world today. We are learning more than ever before about cancer, which helps a growing number of patients with cancer to become survivors of their disease, mainly with the use of new immunotherapies.

Immunotherapy is made up of different types of therapies. Today we have new and exciting treatments and many types of immunotherapies that use the patient’s own immune system to get rid of cancer by attacking the cancer cells.

Share this:

Recommended For You
ImmunotherapyIssue Introductions
The Immunotherapy Surge
By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
In this special issue focused on immunotherapy, we take a deep dive into this exciting type of treatment, highlighting the role of genetic testing and new developments in lung, skin, and bladder cancer in improving patient outcomes.
ImmunotherapyLung CancerPatient Stories
Molecular Profiling and Immunotherapy Offered Me New Hope After Stage IV Lung Cancer Diagnosis
By Christie Bevington
Christie Bevington shares her story of how immunotherapy was the only treatment that helped stop her cancer progression and relieve her back pain caused by lung cancer.
ImmunotherapyMolecular Testing
Molecular Profiling Is Making Cancer Treatment Personal
By Tim Dorius, MD
Tim Dorius, MD, explains the role of molecular profiling in relation to immunotherapy, and how oncologists can now look at the genetic makeup of a tumor to identify specific mutations or other biomarkers.
Bladder CancerImmunotherapyPatient Stories
Hope Against All Odds: My Journey with Immunotherapy for Advanced Bladder Cancer
By Michael Morigi
Michael Morigi shares his very positive experience treating his stage III bladder cancer with immunotherapy.
Last modified: October 12, 2020

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Race or Ethnicity
Profession or Role
Primary Interest